175 related articles for article (PubMed ID: 38151840)
21. Inhibition of SHH pathway mechanisms by arsenic trioxide in pediatric medulloblastomas: a comprehensive literature review.
Klinger PH; Andrade AF; Delsin LE; Queiroz RG; Scrideli CA; Tone LG; Valera ET
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218785
[TBL] [Abstract][Full Text] [Related]
22. Smoothened-activating lipids drive resistance to CDK4/6 inhibition in Hedgehog-associated medulloblastoma cells and preclinical models.
Daggubati V; Hochstelter J; Bommireddy A; Choudhury A; Krup AL; Kaur P; Tong P; Li A; Xu L; Reiter JF; Raleigh DR
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33476305
[TBL] [Abstract][Full Text] [Related]
23. Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma.
Vanner RJ; Remke M; Gallo M; Selvadurai HJ; Coutinho F; Lee L; Kushida M; Head R; Morrissy S; Zhu X; Aviv T; Voisin V; Clarke ID; Li Y; Mungall AJ; Moore RA; Ma Y; Jones SJ; Marra MA; Malkin D; Northcott PA; Kool M; Pfister SM; Bader G; Hochedlinger K; Korshunov A; Taylor MD; Dirks PB
Cancer Cell; 2014 Jul; 26(1):33-47. PubMed ID: 24954133
[TBL] [Abstract][Full Text] [Related]
24. Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development.
Aref D; Moffatt CJ; Agnihotri S; Ramaswamy V; Dubuc AM; Northcott PA; Taylor MD; Perry A; Olson JM; Eberhart CG; Croul SE
Brain Pathol; 2013 Mar; 23(2):178-91. PubMed ID: 22966790
[TBL] [Abstract][Full Text] [Related]
25. mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma.
Wu CC; Hou S; Orr BA; Kuo BR; Youn YH; Ong T; Roth F; Eberhart CG; Robinson GW; Solecki DJ; Taketo MM; Gilbertson RJ; Roussel MF; Han YG
Dev Cell; 2017 Dec; 43(6):673-688.e5. PubMed ID: 29103956
[TBL] [Abstract][Full Text] [Related]
26. Genetic Markers as Predictors for Response to Treatment and Possible Therapeutic Targets in Medulloblastoma.
Pérez-Pineda PL; Ortiz-Butrón R; Pérez-De Marcos JC; Hernández-Regino LM; Zapata-Tarrés MM; Torres-Espíndola LM
CNS Neurol Disord Drug Targets; 2023; 22(5):634-642. PubMed ID: 35579144
[TBL] [Abstract][Full Text] [Related]
27. Medulloblastoma: Molecular Classification-Based Personal Therapeutics.
Archer TC; Mahoney EL; Pomeroy SL
Neurotherapeutics; 2017 Apr; 14(2):265-273. PubMed ID: 28386677
[TBL] [Abstract][Full Text] [Related]
28. Development and cancer of the cerebellum.
Hatten ME; Roussel MF
Trends Neurosci; 2011 Mar; 34(3):134-42. PubMed ID: 21315459
[TBL] [Abstract][Full Text] [Related]
29. The rationale for targeted therapies in medulloblastoma.
MacDonald TJ; Aguilera D; Castellino RC
Neuro Oncol; 2014 Jan; 16(1):9-20. PubMed ID: 24305711
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of CRX, a Group 3-specific oncogenic transcription factor, inhibits TGF-β/activin signaling in medulloblastoma cells.
Masurkar SA; Deogharkar A; Bharambe HS; Shirsat NV
Biochem Biophys Res Commun; 2021 Sep; 568():76-82. PubMed ID: 34192607
[TBL] [Abstract][Full Text] [Related]
31. YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.
Dey A; Robitaille M; Remke M; Maier C; Malhotra A; Gregorieff A; Wrana JL; Taylor MD; Angers S; Kenney AM
Oncogene; 2016 Aug; 35(32):4256-68. PubMed ID: 26725322
[TBL] [Abstract][Full Text] [Related]
32. p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma.
Wei Y; Maximov V; Morrissy SA; Taylor MD; Pallas DC; Kenney AM
Mol Cancer Res; 2019 Jan; 17(1):186-198. PubMed ID: 30224541
[TBL] [Abstract][Full Text] [Related]
33. RalA is overactivated in medulloblastoma.
Ginn KF; Fangman B; Terai K; Wise A; Ziazadeh D; Shah K; Gartrell R; Ricke B; Kimura K; Mathur S; Borrego-Diaz E; Farassati F
J Neurooncol; 2016 Oct; 130(1):99-110. PubMed ID: 27566179
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery.
Strejczek A; Woszczyk D; Urbaniak H; Różańska M; Robak M; Matuszewska Z; Barciszewska AM
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066495
[TBL] [Abstract][Full Text] [Related]
35. The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma.
Lospinoso Severini L; Ghirga F; Bufalieri F; Quaglio D; Infante P; Di Marcotullio L
Expert Opin Ther Targets; 2020 Nov; 24(11):1159-1181. PubMed ID: 32990091
[TBL] [Abstract][Full Text] [Related]
36. Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases.
Markant SL; Esparza LA; Sun J; Barton KL; McCoig LM; Grant GA; Crawford JR; Levy ML; Northcott PA; Shih D; Remke M; Taylor MD; Wechsler-Reya RJ
Cancer Res; 2013 Oct; 73(20):6310-22. PubMed ID: 24067506
[TBL] [Abstract][Full Text] [Related]
37. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
[TBL] [Abstract][Full Text] [Related]
38. Stem-Like Cell Populations, p53-Pathway Activation and Mechanisms of Recurrence in Sonic Hedgehog Medulloblastoma.
Treisman D; Li Y; Zhu Y
Neuromolecular Med; 2022 Mar; 24(1):13-17. PubMed ID: 34165693
[TBL] [Abstract][Full Text] [Related]
39. Hedgehog signaling drives medulloblastoma growth via CDK6.
Raleigh DR; Choksi PK; Krup AL; Mayer W; Santos N; Reiter JF
J Clin Invest; 2018 Jan; 128(1):120-124. PubMed ID: 29202464
[TBL] [Abstract][Full Text] [Related]
40. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ
Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
